Oncternal Therapeutics Inc (ONCT)
8.95
+0.12
(+1.42%)
USD |
NASDAQ |
May 17, 16:00
8.95
0.00 (0.00%)
After-Hours: 16:15
Oncternal Therapeutics Total Liabilities (Quarterly): 6.215M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.215M |
| December 31, 2023 | 6.677M |
| September 30, 2023 | 6.199M |
| June 30, 2023 | 5.589M |
| March 31, 2023 | 5.794M |
| December 31, 2022 | 7.682M |
| September 30, 2022 | 7.626M |
| June 30, 2022 | 7.525M |
| March 31, 2022 | 5.294M |
| December 31, 2021 | 5.465M |
| September 30, 2021 | 5.82M |
| June 30, 2021 | 5.90M |
| March 31, 2021 | 5.754M |
| December 31, 2020 | 5.858M |
| September 30, 2020 | 7.852M |
| June 30, 2020 | 9.301M |
| March 31, 2020 | 7.37M |
| December 31, 2019 | 7.432M |
| September 30, 2019 | 6.899M |
| June 30, 2019 | 7.967M |
| March 31, 2019 | 1.819M |
| December 31, 2018 | 5.21M |
| September 30, 2018 | 9.305M |
| June 30, 2018 | 7.877M |
| March 31, 2018 | 9.61M |
| Date | Value |
|---|---|
| December 31, 2017 | 7.975M |
| September 30, 2017 | 9.279M |
| June 30, 2017 | 5.185M |
| March 31, 2017 | 4.757M |
| December 31, 2016 | 4.611M |
| September 30, 2016 | 3.364M |
| June 30, 2016 | 3.53M |
| March 31, 2016 | 3.019M |
| December 31, 2015 | 30.17M |
| September 30, 2015 | 33.47M |
| June 30, 2015 | 73.17M |
| March 31, 2015 | 29.89M |
| December 31, 2014 | 32.82M |
| September 30, 2014 | 2.40M |
| June 30, 2014 | 3.85M |
| March 31, 2014 | 4.708M |
| December 31, 2013 | 4.921M |
| September 30, 2013 | 5.554M |
| June 30, 2013 | 8.735M |
| March 31, 2013 | 8.637M |
| December 31, 2012 | 10.07M |
| September 30, 2012 | 12.26M |
| June 30, 2012 | 7.456M |
| March 31, 2012 | 5.843M |
| December 31, 2011 | 6.782M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.294M
Minimum
Mar 2022
9.301M
Maximum
Jun 2020
6.711M
Average
6.446M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.14M |
| Shareholders Equity (Quarterly) | 22.93M |